A

Asimov

Genetic design software with engineered cells

Associate Scientist - Cell Line Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$90k - $100k /yrIn-person

About the Job

Requirements

  • A BS or MS in Biological Engineering, Cell Biology, Molecular Biology, or a related field, with 5+ years of hands-on industry experience in mammalian cell engineering and a deep understanding of molecular biology.
  • Experience with transient or stable siRNA knock-downs or knock-outs, inducible or synthetic gene expression systems, or CRISPR-based cell line engineering.
  • Proficiency with spreadsheets such as Google Sheets or Excel, and familiarity with using AI tools for data analysis, visualization, and workflow automation.

Responsibilities

  • Perform CHO cell line development processes, including transfection, cloning, characterization, and cell banking using state-of-the-art equipment.
  • Complete comprehensive documentation of studies in an Electronic Lab Notebook (ELN).
  • Help identify emerging practices for biologics cell line development and manufacturing to shape scientific strategies and develop improved workflows.
  • Contribute to innovation focused on developing novel cell line development workflows and applications.
  • Work on novel, high-impact cell line development research projects beyond standard molecules and workflows, with results intended for publication or patent filings.

Desired Qualifications

  • Experience with CHO cell line development supporting biologic therapies, such as monoclonal antibody therapies, is ideal; candidates with strong mammalian cell engineering backgrounds in other cell types or applications are also encouraged to apply.
  • Familiarity with cell culture liquid-handling automation, flow cytometry, ELISA, ambr bioreactors, or ddPCR on coding or non-coding RNA is a plus.

About the Company

Asimov

Genetic design software with engineered cells

What Asimov does: It provides an integrated synthetic biology platform for biopharma, combining cloud-based software for designing, simulating, and optimizing genetic systems with engineered GMP host cells used for therapeutic production. How its products work: The software lets users design and run simulations of genetic circuits and optimize production processes, while engineered cell lines are used to express proteins or produce viral vectors; services include process development and stability studies. How it differs from competitors: It bundles an end-to-end suite—genetic design software, in-house cell-line development, and process development—along with a performance guarantee, such as a 4 g/L monoclonal antibody titer promise, reducing client risk. What its goal is: To help biopharma customers achieve high yields and scalable production of biologics, gene therapies, and programmable medicines through a tightly integrated platform.

Company size
51-200
Company stage
Series B
Total funding
$204.7M
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Asimov

See more jobs